Chalifah Fatihah
Mayapada Healthcare, operating under the umbrella of PT Sejahteraraya Anugerahjaya Tbk (IDX: SRAJ), has significantly bolstered its oncology services by introducing state-of-the-art Nuclear Medicine and Theranostic technologies, namely PET-CT and SPECT-CT scans, at its Mayapada Hospital Jakarta Selatan (MHJS). This strategic investment positions MHJS as a leading center for advanced cancer diagnosis and treatment in Indonesia, aiming to provide patients with comprehensive, integrated care without the need for international travel.
The newly integrated PET-CT (Positron Emission Tomography-Computed Tomography) and SPECT-CT (Single-Photon Emission Computed Tomography-Computed Tomography) systems represent a significant leap forward in medical imaging capabilities within Indonesia. These sophisticated diagnostic tools are capable of visualizing diseases at the cellular and molecular levels, offering unprecedented insights into the intricate workings of the human body. This advanced imaging allows for the detection of cancerous cells and their metabolic activity with remarkable precision, often before structural changes become apparent through conventional imaging methods.
A New Era in Cancer Diagnosis and Treatment
The introduction of PET-CT and SPECT-CT is a cornerstone of Mayapada Healthcare’s commitment to building a robust and modern Oncology Center network across its facilities. This initiative aims to create a seamless patient journey, from initial diagnosis through to treatment and monitoring, all within a unified and efficient healthcare ecosystem.
Navin Sonthalia, President Director & CEO of Mayapada Healthcare, emphasized the strategic importance of this investment. "Our investment in PET-CT and SPECT-CT is not merely about acquiring new technology; it is a testament to our unwavering commitment to developing a comprehensive and cutting-edge Oncology Center," Sonthalia stated. "We are dedicated to ensuring that our patients receive accurate diagnoses, effective treatments, and ultimately, a better prognosis, eliminating the necessity for them to seek advanced medical care abroad. In conjunction with the development of Tower 3 at Mayapada Hospital Jakarta Selatan, we are solidifying MHJS’s position as a premier center for advanced cancer care and reinforcing its status as one of Indonesia’s largest private hospitals, offering comprehensive, integrated services powered by cutting-edge technology."
Technological Superiority and Patient Benefits
The PET-CT and SPECT-CT systems, sourced from Siemens Healthineers, bring a suite of significant advantages to cancer care at MHJS. These include:
- Enhanced Diagnostic Accuracy: The ability to visualize cellular and molecular activity provides a more precise understanding of tumor characteristics, staging, and potential spread.
- Whole-Body Imaging: These scans can assess the entire body, facilitating the early detection of distant metastases and recurrent disease.
- Sharper Imaging Resolution: Improved image quality aids in better interpretation and identification of subtle abnormalities.
- Reduced Radiation Exposure: Optimized protocols aim to minimize patient exposure to radiation while maintaining diagnostic efficacy.
- Faster Examination Times: Streamlined procedures contribute to a more efficient patient experience.
- Targeted Treatment Planning: Precise imaging allows for more accurate targeting of radiation therapy and surgical interventions.
- Minimized Need for Repeat Scans: Increased accuracy in initial scans can reduce the likelihood of requiring follow-up investigations.
Expansion and Strategic Collaborations
Mayapada Healthcare has ambitious plans for expanding this advanced diagnostic capability. Sonthalia announced that in the coming year, PET-CT and SPECT-CT systems will be deployed at Mayapada Hospital Tangerang (MHTG) and Mayapada Hospital Surabaya (MHSB). Additionally, a PET-CT scanner will be installed at Mayapada Hospital Bandung (MHBD). This phased rollout underscores Mayapada Healthcare’s strategic vision to elevate the quality of care across its entire network.
These advancements are further bolstered by strategic clinical collaborations with world-renowned institutions such as Apollo Hospitals in India and the National University Hospital (NUH) in Singapore. Moreover, MHJS proudly holds Joint Commission International (JCI) accreditation, a globally recognized standard for healthcare quality and patient safety, reinforcing its commitment to international best practices.
A Patient-Centric Approach to Comprehensive Cancer Care
Dr. Fiktorius Kuludong, MM, Hospital Director of Mayapada Hospital Jakarta Selatan, highlighted the hospital’s dedication to an exceptional patient experience. "As the first unit within the Mayapada Hospital network to implement this advanced technology, MHJS is continuously enhancing the overall patient experience. We are committed to serving as a central hub for cancer care for all Mayapada Hospital units, adopting a Comprehensive Cancer Care approach."
Dr. Kuludong elaborated on Mayapada Hospital’s guiding philosophy in managing complex cancer cases: "We adhere to the concept of ‘We Walk Every Journey with C.A.R.E’ – Compassion, Advanced, Responsive, and Experts. We accompany patients and their families throughout their treatment journey with dedicated Patient Navigators, ensuring a coordinated, effective, and comfortable care pathway. This is supported by advanced technology and the expertise of our multidisciplinary medical team within the Tumor Board. This collaborative approach guarantees that every case is handled comprehensively, evidence-based, and personalized, with a strong focus on patient-centered care."
The Role of Nuclear Medicine and Theranostics
The Nuclear Medicine & Molecular Theranostic Center at MHJS is equipped to visualize diseases at the cellular and molecular levels. This capability is not limited to diagnosis; it also enables targeted therapies that specifically attack cancer cells while minimizing harm to healthy tissues. Nuclear therapy procedures are conducted within a Radioactive Isolation Room (RIR), designed with advanced radiation safety systems and natural light, ensuring patient comfort and security during treatment.
Dr. Lim Andreas, Sp.KN, a Nuclear Medicine Specialist at Mayapada Hospital Jakarta Selatan, underscored the critical need for accurate diagnosis in cancer cases. "The primary concern for patients, particularly those suspected of having cancer, is obtaining a definitive and accurate diagnosis. PET-CT and SPECT-CT play an indispensable role for many cancer patients, aiding in early detection, confirming diagnoses, identifying recurrence, and precisely monitoring treatment responses."
Dr. Lim further explained the complementary functions of PET-CT and SPECT-CT: "PET-CT is invaluable for evaluating cellular metabolic activity to detect disease, determine its extent, and monitor treatment effectiveness. SPECT-CT, on the other hand, is used to assess the function of various organs and is crucial for treatment planning."
All procedures utilize safe, standardized doses of radiopharmaceuticals, administered within a 30-180 minute window for optimal distribution, leading to comprehensive scans that facilitate more precise and personalized therapies. The integration of these technologies significantly empowers the multidisciplinary medical teams across Mayapada Hospital’s network to detect and manage cancer more effectively.
Synergy with Siemens Healthineers
The successful implementation of these advanced diagnostic tools is a result of a strong partnership with Siemens Healthineers. Alfred Fahringer, President Director of Siemens Healthineers Indonesia, expressed pride in the collaboration. "We are delighted to partner with Mayapada Healthcare, creating a powerful synergy between Siemens’ technological innovation and Mayapada Healthcare’s clinical expertise. Mayapada Hospital has demonstrated a strong capability in delivering patient-centric services and achieving positive patient outcomes."
Fahringer added, "In the face of the increasing cancer burden in Indonesia, this long-term partnership aims to broaden access to precise cancer diagnostics, enhance the efficiency of clinical practices, and strengthen clinical excellence. We commend Mayapada Healthcare’s commitment to consistently upholding international quality standards, particularly in strengthening integrated oncology services."
To ensure optimal utilization of these advanced systems, Mayapada Healthcare and Siemens Healthineers are jointly implementing comprehensive knowledge transfer programs for medical personnel, covering everything from installation to the effective integration of these technologies into clinical practice.
Conclusion: A Stronger Integrated Oncology Center
Through the integration of cutting-edge technology and the collaborative efforts of its multidisciplinary teams, the Oncology Center at Mayapada Hospital is now more robust than ever. It offers a more definitive diagnosis, more precise treatments, and a more comfortable and reassuring patient experience for individuals battling cancer in Indonesia. This strategic enhancement signifies Mayapada Healthcare’s dedication to advancing cancer care and improving health outcomes for the Indonesian population.
